Davis named CEO at PsiOxus

Solid tumor company PsiOxus Therapeutics Ltd. hired Howard Davis as CEO. Davis most recently worked with Atlas Ventures on the launch of Third Harmonic Bio Inc., where he was also COO. Previously, he was a principal at Flagship Pioneering, and held several roles at Biogen Inc. (NASDAQ:BIIB), including as VP, asset executive of gosuranemab, an extracellular tau protein mAb. Davis succeeds interim CEO Priya Mande, who will take on the new role of COO and U.K. president. 

Evelo Biosciences Inc. (NASDAQ:EVLO) is seeking a successor to President and CEO Simba Gill, who will become chair of the microbiome therapy company and return to Flagship Pioneering as an executive partner. Current Chair Ara Darzi will become lead independent director. Gill, was previously a venture partner at Flagship, and has served as founding CEO of Evelo since 2015. ...